Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10591471
Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
granted -
US 10590182
Binding-triggered transcriptional switches and methods of use thereof
granted -
US 10589250
Automated purification and formulation device for radiopharmaceutical compounds
granted -
US 10588982
Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin
granted -
US 10588897
Piericidin bacterial inhibitors
granted -
US 10588867
Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
granted -
US 10584105
Immunoproteasome inhibitor analogs
granted -
US 10583180
Method for treating adenosine deaminase severe combined imunodeficiency
granted -
US 10577631
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10578608
Tools to detect, track and target cancer cells in vivo
granted -
US 10576079
Multi-drug therapies for tuberculosis treatment
granted -
US 10570419
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10570418
Methods and compositions for RNA-directed target DNA modification
granted -
US 10570124
Deoxycytidine kinase binding compounds
granted -
US 10568844
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules
granted -
US 10563227
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10562886
Anti-cancer compounds
granted -
US 10562839
Medium chain fatty acid esters of β-hydroxybutyrate and butanediol and compositions and methods for using same
granted -
US 10556892
Piperazinyl methanone NAAA inhibitors
granted -
US 10556021
Nanocarriers for drug delivery
granted -
US 10550195
Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
granted -
US 10550163
Peptide fragments of netrin-1 and compositions and methods thereof
granted -
US 10550407
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10544467
Solid tumor methylation markers and uses thereof
granted